Sarah Wagner

Sarah serves as the Senior Director of Business Development within the Commercial team at Crown Bioscience. Since joining the organization in 2019, she has played a pivotal role in engaging with a broad spectrum of clients across the United Kingdom and Europe, providing strategic support throughout all phases of the drug discovery and development process.

She holds a PhD in Cancer Research from Nottingham Trent University. Her doctoral research was centered on the identification of novel biomarkers associated with disease progression and metastasis in prostate cancer. Concurrently, she contributed to research efforts aimed at identifying more reliable biomarkers to predict therapeutic response and resistance in patients with acute myeloid leukemia, with the objective of informing and optimizing treatment decisions.